Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Cyient, Zinier Announce Strategic Partnership to Accelerate Field Service Transformation
2025-07-31 21:00
Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025
2025-07-31 21:00
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO
2025-07-31 20:57
Pop Culture Group's Investment Project "Huaya Times" Officially Launches in Xiamen
2025-07-31 20:45
Autohome Inc. Announces 2025 Q2 Earnings: AI-Driven Product Upgrades and Breakthroughs in Global Expansion
2025-07-31 19:44
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer
2025-07-31 18:36
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
2025-07-31 17:55
Autohome Inc. Announces Unaudited Second Quarter and Interim 2025 Financial Results
2025-07-31 17:30
TAL Education Group Announces Unaudited Financial Results for the First Fiscal Quarter Ended May 31, 2025
2025-07-31 17:00
NetEase Cloud Music Inc. to Report First Half 2025 Financial Results on August 14, 2025
2025-07-31 16:57
Youdao to Report Second Quarter 2025 Financial Results on August 14
2025-07-31 16:30
ZTO to Announce Second Quarter and Half-Year Interim Financial Results of 2025 on August 19, 2025 U.S. Eastern Time
2025-07-31 16:30
NetEase to Report Second Quarter 2025 Financial Results on August 14
2025-07-31 16:30
Ericsson expands 4G and 5G network equipment partnership with SoftBank Corp.
2025-07-31 14:46
Tuniu to Report Second Quarter 2025 Financial Results on August 15, 2025
2025-07-31 14:00
Nscale, Aker ASA and OpenAI to establish Stargate Norway
2025-07-31 13:52
Luxshare Precision Reaffirms Commitment to Cross-Cultural Friendship and Unity Through "Luxshare Cup" Global Relay
2025-07-31 13:49
Agoda launches campaign to drive tourism as Singapore celebrates 60 years of independence
2025-07-31 13:00
Amcor to report fiscal 2025 fourth quarter and full year results
2025-07-31 11:56
Akeso Announces Completion of First Dosing in Phase III Clinical Trial of Ivonescimab (PD-1/VEGF) Combination Therapy for Immunotherapy-Resistant NSCLC
2025-07-31 09:46
1
236
237
238
239
240
3854